Osteoarthritis and Cartilage
Volume 17, Issue 7 , Pages 896-905 , July 2009

Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis

Received 17 June 2008 ,Accepted 10 December 2008.

References 

  1. Rowan AD. Cartilage catabolism in arthritis: factors that influence homeostasis. Rev Mol Med. 2001;3:1–20
  2. Scott DL, Shipley M, Dawson A, Edwards S, Symmons DP, Woolf AD. The clinical management of rheumatoid arthritis and osteoarthritis: strategies for improving clinical effectiveness. British J Rheumatol. 1998;37:546–554
  3. Mow VC, Setton LS, Guilak F, Ratcliffe A. Mechanical factors in articular cartilage and their role in osteoarthritis. Osteoarthritis Disorders. American Acad Orthopedic Surgeons. 1995;147–171
  4. Mort JS, Billington CJ. Articular cartilage and changes in arthritis: matrix degradation. Arthritis Res. 2001;3:337–341
  5. Hughes CE, Little CB, Buttner FH, Bartnik E, Caterson B. Differential expression of aggrecanase and matrix metalloproteinase activity in chondrocytes isolated from bovine and porcine articular cartilage. J Biol Chem. 1998;273:30576–30585
  6. Watanabe H, Yoshihiko Y, Kimata K. Roles of aggrecan: a large chondroitin sulphate proteoglycan, in cartilage structure and function. J Biochem (Tokyo). 1998;124:687–693
  7. Sandy JD, Westling J, Kenagy RD, Iruela-Arispe PL, Verscharen C, Rodriguez-Mazaneque JC, et al. Versican VI proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem. 2001;276:13372–13378
  8. Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, et al. Cloning and characterisation of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem. 1999;274:23443–23450
  9. Arner EC, Pratta MA, Trzaskos JM, Decicco CP, Tortorella MD. Generation and characterisation of aggrecanase. A soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem. 1999;274:6594–6601
  10. Glasson SS, Askew R, Sheppard B, Carito B, Blanche T, Ma H-L, et al. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice. Arthritis Rheum. 2004;50:2547–2558
  11. Stanton H, Frazer M, Rogerson CJ, East SB, Golub KE, Lawlor CT, et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature. 2005;434:648–652
  12. Glasson SS, Askew R, Sheppard B, Carito B, Blanche T, Ma H-L, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature. 2005;434:644–648
  13. Tortorella MD, Malfait AM, Deccico C, Arner E. The role of ADAMTS-4 (aggrecanase-1) and ADAMTS-5 (aggrecanase-2) in a model of cartilage degradation. Osteoarthritis Cartilage. 2001;9:539–552
  14. Gendron C, Kashiwagi M, Lim NH, Enghild JJ, Thogersen IB, Hughes C, et al. Proteolytic activities of human ADAMTS-5; comparative studies with ADAMTS-4. J Biol Chem. 2007;282:18294–18306
  15. Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 2004;50:131–141
  16. Clarke IM, Parker AE. Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets. 2005;7:19–34
  17. Walakovits lA, Moore VL, Bhardwaj N, Gallick GS, Lark MW. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and post-traumatic knee injury. Arthritis Rheum. 1992;35:35–42
  18. Cawston T. Matrix metalloproteinases and TIMPS: properties and implications for the rheumatic diseases. Mol Med Today. 1998;9:130–137
  19. Calder PC. n-3 Polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?. Nutri Res. 2001;21:309–341
  20. Gurr MI, Harwood JL, Frayn KN. Lipid Biochemistry. Fifth edn. Oxford: Blackwells Scientific; 2002;
  21. Harwood JL, Caterson B. Dietary omega-3 polyunsaturated fatty acids and inflammation. Lipid Technol. 2006;18:7–10
  22. Serhan CH, Gotlinger K, Hong S, Arita M. Resolvins, docosatrienes and neuroprotectins, novel omega-3-derived mediators and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. Prostaglandins Other Lipid Mediat. 2004;73:155–172
  23. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495–505
  24. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999;70:560–569
  25. Dubois RN, Abramson SB, Crofford A, Gupta R, Simon LS, Van de Putte LBA, et al. Cyclooxygenase in biology and disease. FASEB J. 1998;12:1063–1073
  26. Fiorucci S, Meli R, Bucci M, Cirino G. Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy?. Biochem Pharmacol. 2001;62:1433–1438
  27. Smith C, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A. 1998;95:13313–13318
  28. Vane JR, Bakhle YS, Botting RM. Cyclooxygenase 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97–120
  29. Mitchell JA, Warner TD. Cyclooxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Brit J Pharmacol. 1999;128:1121–1132
  30. Drazen JM. A lesson in unexpected problems. New Engl J Med. 2005;352:1131–1132
  31. Cunnane SC. Problems with essential fatty acids: time for a new paradigm?. Prog Lipid Res. 2003;42:544–568
  32. ISSFAL . Recommendation for intake of polyunsaturated fatty acids in healthy adults. ISSFAL Newsl. 2004;11:12–25
  33. Morris MC, Evans DA, Bienias JL, Tanguey CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60:940–946
  34. Garbus J, De Luca HF, Loomans ME, Strong FM. The rapid incorporation of phosphate in mitochondrial lipids. J Biol Chem. 1963;238:59–63
  35. Arkill KP, Winlove CP. Fatty acid transport in articular cartilage. Arch Biochem Biophys. 2006;456:71–78
  36. Zainal Z. How can palm oil be modified to give improved dietary benefits?. Ph.D. thesis, University of Cardiff, UK, 2005.
  37. Aydelotte MB, Raiss RX, Caterson B, Kuettner KE. Influence of interleukin-1 on the morphology and proteoglycan metabolism of cultured bovine articular chondrocytes. Connect Tissue Res. 1992;28:143–159
  38. Brooks P, Emery P, Evans JF, Fenner H, Hawkey CJ, Patrono CJ. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology. 1999;38:779–788
  39. Pelletier JH, Alaaeddine N, Pelletier JP. Cytokines and their role in the pathophysiology of osteoarthritis. Frontiers Bioscience. 1999;4:694–703
  40. Calder PC. n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored. Clin Sci. 2004;107:1–11
  41. Harwood JL. Human dietary requirements. In:  Gunstone FD,  Harwood JL,  Dijkstra AJ editor. The Lipid Handbook. Third edn. Boca Raton, Fl: Taylor and Francis; 2007;p. 703–710
  42. Kim HH, Cho S, Lee S, Kim KH, Cho KH, Eun HC, et al. Photoprotective and anti-skin-aging effects of eicosapentaenoic acid in human skin in vitro. J Lipid Res. 2006;47:921–930
  43. Massaro M, Habid A, Lubrano L, Del Turco S, Lazzerini G, Bourcier T, et al. The omega-3 fatty acid decosahexaenoate attenuates endothelial cyclooxygenase-2 induction through both NADP(H) oxidase and PKCE inhibition. Proc Natl Acad Sci U S A. 2006;103:15184–15189
  44. Clarke SD. Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome. J Nutr. 2001;131:1129–1132
  45. Jump DB. The biochemistry of n-3 polyunsaturated fatty acids. J Biol Chem. 2002;277:8755–8758
  46. Hurst S. n-3 polyunsaturated fatty acid effects on inflammatory mediator activity and intracellular signalling pathways in chondrocyte metabolism. Ph.D. thesis, University of Cardiff, UK, 2004.
  47. Qi B, Frazer T, Mugford S, Dobson G, Sayanova O, Butler J, et al. Production of very long chain polyunsaturated omega-3 and omega-6 fatty acids in plants. Nature Biotechnol. 2004;22:739–745
  48. Wu G, Truksa M, Datla N, Vrinten P, Bauer J, Zank T, et al. Stepwise metabolic engineering of economically significant amounts of very long chain polyunsaturated fatty acids in seeds of Brassica juncea. Nature Biotechnol. 2005;23:1013–1017

PII: S1063-4584(08)00382-8

doi: 10.1016/j.joca.2008.12.009

Osteoarthritis and Cartilage
Volume 17, Issue 7 , Pages 896-905 , July 2009

Article Tools

* Image Usage & Resolution